Concord Biotech Expands: New Injectable Facility & Ambitious Growth Plans! | MCap 19,631.23 Cr | PE 59.72 Concord Biotech is gearing up for a 25% CAGR over the next 5 years, fueled by new product additions and customer expansion! 🌟 🔍 Key Highlights: - Q3FY25 Revenue: Rs. 244.2 crore, marking a 1% YoY growth. - EBITDA Margin: 40.1%, with a Profit After Tax of Rs. 75.9 crore. - API Segment Revenue: Grew by 3% YoY, despite some revenue spillover to the next quarter. - Targeting a 25% CAGR over the next 5 years through new products and customer expansion. - Exploring global CDMO/CMO opportunities. - 9M Revenue (Dec 31, 2024): Rs. 770.2 crore, a 10% increase from the previous year. - Gross Profit Margin: Slightly decreased to 78.5% from 80.4% in Q3FY24. - Formulation business, started in 2016, is expanding into injectables with a new facility. - Diverse portfolio with over 30 fermentation-based APIs in 70+ countries. - Committed to sustainability with ISO-14001:2015 & ISO-45001:2018 certifications. 🔹Company Profile: Name: Concord Biotech Ltd Symbol: CONCORDBIO, BSE:543960 PE: 59.72 Market Cap: ₹19,631.23 Cr. == Approx. $2.35 B Sector: Healthcare - Pharmaceuticals 💬What do you think about this new development? Share your thoughts in the comments! 🕒 This update of Concord Biotech Ltd was recorded at February 14, 2025, 10:51 AM Complete Source: Follow us for more realtime updates! Disc: Information provided in this tweet can be inaccurate, verify through the source before making any investment decision. Preview 👇 (First 4 out of 26 pages)

Garware HiTech Films Ltd: Strategic Expansion and Promising Future Ahead! | MCap 9,368.35 Cr | PE 27.31 🚀 Garware HiTech Films is set for growth with a ₹118 crore investment in a new TPU extrusion line, aiming for ₹2,500 crores in revenue by FY '26! 📈 📊 Key Highlights: - Earnings call on February 10, 2025, revealed Q3 results for the nine months ending December 31, 2024. - Consolidated revenue: ₹466.4 crores; Profit after tax: ₹60.8 crores for the quarter. - CPD segment down 7% YoY; IPD segment up 24% due to market penetration. - Revenue increased 2.5x since 2018; EBITDA margins improved to 24% annually. - Board approved ₹118 crores for a TPU extrusion line at Waluj plant, completion by October 2026. - New TPU line to enhance PPF production and operational efficiency. - Launched two advanced PPF variants at Bharat Mobility Global Expo 2025. - EMI solutions with Bajaj Finance and PPF Insurance with Insurance Dekho introduced. - Sun Control Films business grew 15% YoY, driven by architectural expansion. - IPD segment growth supported by strong demand and a new patent for floatable shrink film. - Strong financial position: ₹572 crores cash surplus and zero net debt as of December 31, 2024. - Confident in achieving FY '25 and '26 guidance with a target of ₹2,500 crores for FY '26. 🔹Company Profile: Name: Garware HiTech Films Ltd Symbol: GRWRHITECH, BSE:500655 PE: 27.31 Market Cap: ₹9,368.35 Cr. == Approx. $1.12 B Sector: Capital Goods - Plastic Products - Industrial 💬 What do you think about this new development? Share your thoughts in the comments! 🕒 This update of Garware HiTech Films Ltd was recorded at February 14, 2025, 10:51 AM Complete Source: Follow us for more realtime updates! Disc: Information provided in this tweet can be inaccurate, verify through the source before making any investment decision. Preview 👇 (First 4 out of 25 pages)

GAIL (India) Ltd: Pioneering Clean Energy Initiatives! | MCap 1,06,779.62 Cr | PE 14.16 🌱 GAIL is set to revolutionize India's energy landscape with 26 new CBG plants and an accelerated 'Net Zero' target by 2035! 🚀 🔑 Key Highlights: - GAIL (India) Limited & Cummins Inc. signed an MoU on February 13, 2025, for clean energy collaboration. - The MoU focuses on sustainable energy and energy transition technologies in India. - GAIL is moving its 'Net Zero' targets from 2040 to 2035. - Cummins' Accelera™ division is a leader in zero-emissions technologies. - A 10 MW Green Hydrogen unit was commissioned by GAIL in Vijaipur, Madhya Pradesh in April 2024. - Pilot studies are underway for blending hydrogen with CNG/PNG, scaling from 2% to 5%. - GAIL plans to establish 26 CBG plants across India in the next 3-4 years. - Joint ventures include a 10 CBG plant project with Leafiniti Bioenergy and a 500 KLPD grain-based ethanol plant in Rajasthan. - The MoU will investigate hydrogen applications in transport, power, and steel industries, including blending with natural gas. 🔹Company Profile: Name: GAIL (INDIA) LTD Symbol: GAIL, BSE:532155 PE: 14.16 Market Cap: ₹1,06,779.62 Cr. == Approx. $12.79 B Sector: Oil, Gas & Consumable Fuels - Gas Transmission/Marketing 💬 What do you think about this new development? Share your thoughts in the comments! Follow us for more realtime updates! 🕒 This update of GAIL (INDIA) LTD was recorded at February 14, 2025, 10:37 AM Disc: Information provided in this tweet can be inaccurate, verify through the source before making any investment decision.

Elgi Equipments Ltd: Pioneering Compressor Technology & Strategic Growth Plans | MCap 15,770.98 Cr | PE 45.91 🚀 Elgi Equipments is set to revolutionize the compressor market with a new patented technology and ambitious growth targets! 💡 📊 Key Highlights: - Analyst conference held on February 11, 2025, discussing Q3 2024-25 results. - Fixed costs rose by 15% due to one-time expenses like transport and warranty provisioning. - GST portal downtime led to a loss of ~15 crores in sales, impacting revenue growth. - Despite challenges, a 3% revenue growth was reported, alongside a strong cash position. - Launch of a global patented compressor technology aimed at significant energy savings for customers. - New technology enables compressors to operate at constant speed, enhancing efficiency and reliability. - Plans to introduce low-cost compressors targeting a 200 crores market in India to compete with Chinese imports. - Aiming to break even in Europe and North America by FY26, focusing on strategic markets. - Confident in achieving strong Q4 performance with anticipated 9-10% steady-state growth and potential from new products. - Increased market share in oil-lubricated screw compressors, targeting global leadership in strategic geographies. 🔹Company Profile: Name: ELGI EQUIPMENTS LTD Symbol: ELGIEQUIP, BSE:522074 PE: 45.91 Market Cap: ₹15,770.98 Cr. == Approx. $1.89 B Sector: Capital Goods - Compressors, Pumps & Diesel Engines 💬 What do you think about this new development? Share your thoughts in the comments! 🕒 This update of ELGI EQUIPMENTS LTD was recorded at February 14, 2025, 10:34 AM Complete Source: Follow us for more realtime updates! Disc: Information provided in this tweet can be inaccurate, verify through the source before making any investment decision. Preview 👇 (First 4 out of 20 pages)

Laxmi Dental Ltd: Strong Growth Ahead! 📈 | MCap 2,290.27 Cr Laxmi Dental is on track for impressive growth, expecting FY25 revenues of ₹2,400 million! 🚀 📊 Key Highlights: - Laxmi Dental Ltd reported Q3FY25 revenues of ₹616.6 million, up 29% from ₹477.9 million in Q3FY24. - Gross profit for Q3FY25 reached ₹455.7 million, a 32.1% year-over-year increase. - EBITDA soared to ₹96.1 million, a remarkable 144.7% rise compared to ₹39.3 million in Q3FY24. - Profit After Tax (PAT) for Q3FY25 was ₹48.2 million, marking a 105% increase from ₹23.5 million in Q3FY24. - Adjusted EBITDA, including Kids-e-Dental's profit share, stood at ₹107.9 million for Q3FY25. - The company has repaid approximately ₹126 million of borrowings post-IPO, aiming to reduce debt significantly. - Laxmi Dental anticipates closing FY25 with revenues around ₹2,400 million and a PAT margin of 13% to 15%. - Expected growth rate of 20% to 25% CAGR over the next 3-5 years, fueled by rising demand for dental care. - Laxmi Dental is India's only end-to-end integrated dental products company and the largest exporter among Indian dental labs. 🔹Company Profile: Name: Laxmi Dental Ltd Symbol: LAXMIDENTL, BSE:544339 Market Cap: ₹2,290.27 Cr. == Approx. $0.27 B Sector: Healthcare - Medical Equipment & Supplies 💬 What do you think about this new development? Share your thoughts in the comments! Follow us for more realtime updates! 🕒 This update of Laxmi Dental Ltd was recorded at February 14, 2025, 10:17 AM Disc: Information provided in this tweet can be inaccurate, verify through the source before making any investment decision.

BCL Industries Ltd: Expanding Horizons in Sustainable Energy! | MCap 1,172.39 Cr | PE 16.58 BCL Industries is on the move! 🚀 Expanding distillery capacity and launching a Bio-CNG plant to support India's energy transition. 🌱 📊 Key Highlights: - BCL Industries Ltd has submitted an Investor Presentation on the Un-audited Financial Results for the quarter and nine months ended December 31, 2024. - Celebrating 50 years of strong legacy in the agro-processing industry. - Leading grain-based ethanol producer in India, focused on reducing crude import bills. - Expanding distillery capacity from 700 KLPD to 1,100 KLPD in Haryana and Bathinda. - Establishing a 20 MTPD Bio-CNG plant using 200 MT paddy straw daily to combat stubble burning. - Strong presence in the ENA and IMIL segments, strategically positioned in the ethanol market. - Plans to phase out edible oil business by Q1FY26. - Expected full capacity utilization of 700 KLPD distillery in FY 24-25, with revenue over Rs 1,750 crores. - Working on a 75 KLPD biodiesel plant in Bathinda, commissioning in 3-4 months. - Comfortable debt repayment schedule with average cash flow from operations exceeding Rs 50 crore from FY2022-24. 🔹Company Profile: Name: BCL Industries Ltd Symbol: BCLIND, BSE:524332 PE: 16.58 Market Cap: ₹1,172.39 Cr. == Approx. $0.14 B Sector: Fast Moving Consumer Goods - Breweries & Distilleries 💬 What do you think about this new development? Share your thoughts in the comments! 🕒 This update of BCL Industries Ltd was recorded at February 14, 2025, 10:15 AM Complete Source: Follow us for more realtime updates! Disc: Information provided in this tweet can be inaccurate, verify through the source before making any investment decision. Preview 👇 (First 4 out of 48 pages)

@Keyur_patel21 Hi Keyur, as Ravi mentioned, source is given at the end of the tweet & everything in the tweet is summarised from the source.

Laxmi Dental Ltd: Strong Growth and Ambitious Expansion Plans! | MCap 2,290.27 Cr Laxmi Dental Ltd is on the rise! 🚀 Expecting revenues of ₹2,400 million with a PAT margin of 13-15% this financial year. 📈 📊 Key Highlights: - Q3 FY25 revenues hit ₹617 million, a 29% YoY growth! - Adjusted EBITDA stands at ₹108 million, with a PAT of ₹48 million. - Projected FY revenues around ₹2,400 million and PAT margin of 13-15%. - Successful IPO in January 2025 raised ₹6,980 million. - Only integrated dental products company in India with a diverse product portfolio. - Growth across all segments, with Aligners leading the way. - Expanding international presence with a network of 22,000+ dental clinics and professionals. - Focused on boosting manufacturing capacities and enhancing branded offerings. - Embracing tech advancements in digital dentistry for efficiency and cost reduction. - Strong management team with extensive industry experience, ready to seize opportunities. 🔹Company Profile: Name: Laxmi Dental Ltd Symbol: LAXMIDENTL, BSE:544339 Market Cap: ₹2,290.27 Cr. == Approx. $0.27 B Sector: Healthcare - Medical Equipment & Supplies 💬 What do you think about this new development? Share your thoughts in the comments! 🕒 This update of Laxmi Dental Ltd was recorded at February 14, 2025, 09:57 AM Complete Source: Follow us for more realtime updates! Disc: Information provided in this tweet can be inaccurate, verify through the source before making any investment decision. Preview 👇 (First 4 out of 41 pages)

@RaajJPateel Thanks for pointing it out. Have Corrected in the reply.

*Correction: Estimated Completion Date is 31st March, 2025.

Glenmark Pharmaceuticals Expands Ophthalmic Portfolio with New Launch! | MCap 39,785.71 Cr | PE 7.05 🚀 Glenmark Pharmaceuticals has just launched Latanoprost Ophthalmic Solution, marking a significant expansion in their ophthalmic offerings! 🌍💊 🔑 Key Highlights: - Glenmark Pharmaceuticals Inc., USA launched Latanoprost Ophthalmic Solution, 0.005% (0.05 mg/mL) on February 14, 2025. - The product is bioequivalent and therapeutically equivalent to Upjohn US 2 LLC's Xalatan® Ophthalmic Solution, 0.005%. - Xalatan® achieved annual sales of approximately $113.5 million for the 12-month period ending December 2024. - This is Glenmark's fourth ophthalmic product, enhancing their portfolio in the ophthalmic channel. - Glenmark is ranked among the Top 100 biopharmaceutical companies by Pharmaceutical Sales in 2023. - The company operates 11 manufacturing facilities across 4 continents and is present in over 80 countries. - Glenmark's Green House Gas emission reduction targets were approved by the Science Based Target initiative in 2023. 🔹Company Profile: Name: GLENMARK PHARMACEUTICALS LTD Symbol: GLENMARK, BSE:532296 PE: 7.05 Market Cap: ₹39,785.71 Cr. == Approx. $4.76 B Sector: Healthcare - Pharmaceuticals 💬 What do you think about this new development? Share your thoughts in the comments! Follow us for more realtime updates! 🕒 This update of GLENMARK PHARMACEUTICALS LTD was recorded at February 14, 2025, 08:50 AM Disc: Information provided in this tweet can be inaccurate, verify through the source before making any investment decision.

Senco Gold Ltd: Major Capacity Expansion and Record Revenue! | MCap 7,312.32 Cr | PE 26.06 Senco Gold Ltd expands its showroom portfolio to 171 and plans to open 8-10 new locations in Q4 FY25! 🚀💰 📊 Key Highlights: - Senco Gold Limited released its investor presentation for the quarter and nine months ending December 31, 2024. - Successfully raised INR 459 crore through a Qualified Institutional Placement (QIP) to repay short-term debt and support expansion plans. - Announced a 1:2 stock split on January 31, 2025, to enhance shareholder value. - Achieved highest-ever Q3 revenue of INR 2,000 crore, with a single-month revenue of INR 1,000 crore during Dhanteras, marking a 22% YoY growth. - Reported 21% growth in gold jewellery, 9% in diamond jewellery, 35% in silver jewellery, and 18% in Gossip jewellery. - Expanded showroom portfolio to 171, including 70 franchisee showrooms, with plans to open 8-10 new showrooms in Q4 FY25. - Aiming for a 7%-8% EBITDA margin annually, with adjusted EBITDA for the 9-month period at INR 298.0 crore and an adjusted EBITDA margin of 6.0%. - Adjusted PAT for the quarter was INR 53.8 crore, with a YTD PAT of INR 96.9 crore and an adjusted PAT of INR 138.8 crore. - Management highlighted the impact of gold price volatility and hedging practices on quarterly EBITDA margins, with a long-term target of 7%-8% EBITDA margin. - Focus on expanding market presence, leveraging an asset-light franchise model, and enhancing customer experience through digital platforms and innovative product offerings. 🔹Company Profile: Name: Senco Gold Ltd Symbol: SENCO, BSE:543936 PE: 26.06 Market Cap: ₹7,312.32 Cr. == Approx. $0.88 B Sector: Consumer Durables - Gems, Jewellery And Watches 💬 What do you think about this new development? Share your thoughts in the comments! 🕒 This update of Senco Gold Ltd was recorded at February 14, 2025, 08:09 AM Complete Source: Follow us for more realtime updates! Disc: Information provided in this tweet can be inaccurate, verify through the source before making any investment decision. Preview 👇 (First 4 out of 51 pages)

Major Order Boost for Premier Energies Ltd! 🚀 | MCap 45,136.04 Cr Premier Energies Photovoltaic Private Limited secures a whopping order worth INR 1234 Crore! 💰 📊 Key Highlights: - Company: Premier Energies Photovoltaic Private Limited - Order Value: INR 1234 Crore - Significance: A substantial boost to the company's order book! 🔹Company Profile: Name: Premier Energies Ltd Symbol: PREMIERENE, BSE:544238 Market Cap: ₹45,136.04 Cr. == Approx. $5.41 B Sector: Capital Goods - Other Electrical Equipment 💬 What do you think about this new development? Share your thoughts in the comments! Follow us for more realtime updates! 🕒 This update of Premier Energies Ltd was recorded at February 14, 2025, 08:03 AM Disc: Information provided in this tweet can be inaccurate, verify through the source before making any investment decision.

Senco Gold Ltd: A Strong Expansion and Record Revenue! | MCap 7,312.32 Cr | PE 26.06 Senco Gold Ltd achieves record revenue of ₹2,100 Cr in Q3 FY25! 🚀✨ 📊 Key Highlights: - Highest-ever quarterly revenue of over ₹2,100 Cr for Q3 FY25, up 27.3% YoY. - Consolidated revenue growth of 22% for the nine months ending December 31, 2024. - Adjusted EBITDA margin: 5.1% for Q3, 6% for nine months (below guidance of 7-8%). - Profit After Tax (PAT) for Q3: ₹334.8 Cr; adjusted PAT: ₹537.4 Cr. - Raised ₹2,459 Cr through QIP for debt repayment and expansion. - Expanded showroom portfolio to 171, including 70 franchisee showrooms; plans for 8-10 new showrooms in Q4 FY25. - Gold prices up 22% YoY, yet strong consumer demand during Dhanteras and Diwali. - Launched new marketing campaigns and established Sennes Fashion Limited for lifestyle expansion. - Recognized as the 2nd Most Trusted Jewellery Brand with a credit rating upgrade from ICRA. 🔹Company Profile: Name: Senco Gold Ltd Symbol: SENCO, BSE:543936 PE: 26.06 Market Cap: ₹7,312.32 Cr. == Approx. $0.88 B Sector: Consumer Durables - Gems, Jewellery And Watches 💬 What do you think about this new development? Share your thoughts in the comments! Follow us for more realtime updates! 🕒 This update of Senco Gold Ltd was recorded at February 14, 2025, 06:35 AM Disc: Information provided in this tweet can be inaccurate, verify through the source before making any investment decision.

Senco Gold Ltd: A Major Expansion and Record Revenue! | MCap 7,312.32 Cr | PE 26.06 Senco Gold Ltd hits a record quarterly revenue of ₹2,100 Cr! 🚀 With plans for more showrooms, the future looks bright! 🌟 📊 Key Highlights: - Highest-ever quarterly revenue of over ₹2,100 Cr for Q3 FY25, up 27.3% YoY. - Consolidated revenue growth of 22% for the nine months ending December 31, 2024. - Adjusted EBITDA margin: 5.1% for Q3, 6% for nine months (guidance: 7-8%). - Profit After Tax (PAT) for Q3: ₹334.8 Cr; adjusted PAT: ₹537.4 Cr. - Standalone revenue growth: 22.5% in Q3, 19.4% for nine months; retail growth of 19% in Q3. - Raised ₹459 Cr through QIP for debt repayment and expansion. - Announced a 1:2 stock split on January 31, 2025, to boost shareholder value. - Gold prices up 22% YoY, yet consumer demand remains strong during Dhanteras and Diwali. - Expanded showroom portfolio to 171, including 70 franchisee showrooms; plans for 8-10 new showrooms in Q4 FY25. - Launched new campaigns and incorporated Sennes Fashion Limited for lifestyle segment. 🔹Company Profile: Name: Senco Gold Ltd Symbol: SENCO, BSE:543936 PE: 26.06 Market Cap: ₹7,312.32 Cr. == Approx. $0.88 B Sector: Consumer Durables - Gems, Jewellery And Watches 💬 What do you think about this new development? Share your thoughts in the comments! Follow us for more realtime updates! 🕒 This update of Senco Gold Ltd was recorded at February 14, 2025, 06:19 AM Disc: Information provided in this tweet can be inaccurate, verify through the source before making any investment decision.

Laxmi Dental Ltd: Strong Growth Ahead! 📈 | MCap 2,303.74 Cr Laxmi Dental is on track for impressive growth, expecting FY25 revenues of ₹2,400 million! 🚀 📊 Key Highlights: - Q3FY25 revenues: ₹616.6 million, up 29% YoY from ₹477.9 million in Q3FY24. - Gross profit for Q3FY25: ₹455.7 million, a 32.1% increase YoY. - EBITDA soared to ₹96.1 million, a remarkable 144.7% rise from ₹39.3 million in Q3FY24. - Profit After Tax (PAT) reached ₹48.2 million, a 105% increase from ₹23.5 million in Q3FY24. - Adjusted EBITDA, including Kids-e-Dental's profit share: ₹107.9 million for Q3FY25. - Debt reduction: Approximately ₹126 million repaid post-IPO. - FY25 revenue forecast: ₹2,400 million with a PAT margin of 13% to 15%. - Anticipated growth rate: 20% to 25% CAGR over the next 3-5 years, fueled by rising dental care demand. - Laxmi Dental: India's only end-to-end integrated dental products company and the largest exporter among Indian dental labs. 🔹Company Profile: Name: Laxmi Dental Ltd Symbol: LAXMIDENTL, BSE:544339 Market Cap: ₹2,303.74 Cr. == Approx. $0.28 B Sector: Healthcare - Medical Equipment & Supplies 💬 What do you think about this new development? Share your thoughts in the comments! Follow us for more realtime updates! 🕒 This update of Laxmi Dental Ltd was recorded at February 14, 2025, 01:51 AM Disc: Information provided in this tweet can be inaccurate, verify through the source before making any investment decision.

Laxmi Dental Ltd: Strong Growth and Ambitious Future Ahead! | MCap 2,303.74 Cr 📈 Laxmi Dental Ltd is on track for a remarkable FY25 with projected revenues of ₹2,400 million and a PAT margin of 13% to 15%! 🚀 🔑 Key Highlights: - Q3 FY25 revenue: ₹617 million, up 29% YoY. - Adjusted EBITDA for Q3 FY25: ₹108 million; PAT: ₹48 million. - FY25 revenue forecast: ₹2,400 million with a PAT margin of 13% to 15%. - Successful IPO in January 2025, raising ₹6,980 million. - Diverse product portfolio: aligners, lab offerings, and pediatric dental products. - Second largest in domestic lab business; largest export lab. - Aligner solutions revenue surged 7x from FY22 to FY24. - Extensive network: 22,000+ dental clinics and dentists across 300+ cities. - Focus on expanding manufacturing and enhancing branded products. - Strong financial growth with significant revenue and profitability increases. 🔹Company Profile: Name: Laxmi Dental Ltd Symbol: LAXMIDENTL, BSE:544339 Market Cap: ₹2,303.74 Cr. == Approx. $0.28 B Sector: Healthcare - Medical Equipment & Supplies 💬 What do you think about this new development? Share your thoughts in the comments! 🕒 This update of Laxmi Dental Ltd was recorded at February 14, 2025, 01:43 AM Complete Source: Follow us for more realtime updates! Disc: Information provided in this tweet can be inaccurate, verify through the source before making any investment decision. Preview 👇 (First 4 out of 41 pages)

Concord Enviro Systems Ltd: Expanding Horizons with New Ventures! | MCap 1,353.12 Cr 🚀 Exciting growth at Concord Enviro Systems! They've expanded into compressed biogas plants and O&M services while reporting impressive revenue growth! 📈 📊 Key Highlights: - Investor presentation reveals financial performance for the quarter/nine months ending December 31, 2024. - 31% year-over-year increase in consolidated revenue, reaching Rs. 3,874 million. - Consolidated EBITDA decreased by 20% to Rs. 335.76 million; PAT fell by 67% to Rs. 43.62 million. - Order book totals Rs. 5,460 million (55% domestic, 45% international). - Active domestic pipeline: Rs. 8,000 million; international pipeline: Rs. 3,500 million. - Leading provider of wastewater treatment and zero liquid discharge (ZLD) solutions. - Awarded 4 patents in India with 9 additional applications pending. - New business lines include compressed biogas (CBG) plants and third-party O&M services. - Diverse customer base: 289 domestic and 21 international customers across 14 countries. - Successfully listed on NSE and BSE mainboard in 2024. 🔹Company Profile: Name: Concord Enviro Systems Ltd Symbol: CEWATER, BSE:544315 Market Cap: ₹1,353.12 Cr. == Approx. $0.16 B Sector: Utilities - Waste Management 💬 What do you think about this new development? Share your thoughts in the comments! 🕒 This update of Concord Enviro Systems Ltd was recorded at February 14, 2025, 12:10 AM Complete Source: Follow us for more realtime updates! Disc: Information provided in this tweet can be inaccurate, verify through the source before making any investment decision. Preview 👇 (First 4 out of 25 pages)

Concord Enviro Systems Ltd: Order Book Reaches ₹5,460 Million! | MCap 1,353.12 Cr 📊 Exciting news! Concord Enviro Systems Ltd's order book has hit ₹5,460 million, with a strong mix of domestic and international orders! 🌍 🔑 Key Highlights: - Total Order Value: ₹5,460 million - Domestic Orders: 55% of total - International Orders: 45% of total 🔹Company Profile: Name: Concord Enviro Systems Ltd Symbol: CEWATER, BSE:544315 Market Cap: ₹1,353.12 Cr. == Approx. $0.16 B Sector: Utilities - Waste Management 💬 What do you think about this new development? Share your thoughts in the comments! 🕒 This update of Concord Enviro Systems Ltd was recorded at February 14, 2025, 12:10 AM Complete Source: Follow us for more realtime updates! Disc: Information provided in this tweet can be inaccurate, verify through the source before making any investment decision. Preview 👇 (First 4 out of 25 pages)

Concord Enviro Systems Ltd: Capacity Expansion Update 🚀 | MCap 1,353.12 Cr Concord Enviro Systems Ltd has successfully utilized INR 12.108 Crore for its greenfield project! 🌱 📊 Key Highlights: - Monitoring Agency Report for Q4 2024 submitted on February 13, 2025. - Report by ICRA Limited confirms no deviation from IPO proceeds usage. - IPO conducted from December 19-23, 2024, with a total issue size of INR 500.326 Crore. - Revised net proceeds from IPO stand at INR 162.076 Crore due to higher expenses. - Report reviewed by Audit Committee and approved by the Board on February 13, 2025. - All necessary government approvals for the issue have been obtained. - INR 12.108 Crore utilized for the greenfield project; INR 3.309 Crore remains unutilized. - Investment in subsidiaries and projects is on schedule with no delays reported. 🔹Company Profile: Name: Concord Enviro Systems Ltd Symbol: CEWATER, BSE:544315 Market Cap: ₹1,353.12 Cr. == Approx. $0.16 B Sector: Utilities - Waste Management 💬 What do you think about this new development? Share your thoughts in the comments! 🕒 This update of Concord Enviro Systems Ltd was recorded at February 13, 2025, 11:40 PM Complete Source: Follow us for more realtime updates! Disc: Information provided in this tweet can be inaccurate, verify through the source before making any investment decision. Preview 👇 (First 4 out of 11 pages)